Read more about the latest developments in infant nutrition in Singapore and China, nootropics in Australia, food fortification in India, personalised nutrition in Japan and more in our 10 most read APAC nutrition stories for August.
Click through the gallery to see them all.
Read more about the latest developments in infant nutrition in Singapore and China, nootropics in Australia, food fortification in India, personalised nutrition in Japan and more in our 10 most read APAC nutrition stories for August
Click through the gallery to see them all.
Singapore's Agri-Food & Veterinary Authority (AVA) has recalled a batch of Dumex Mamil Gold Infant Milk Formula - Step 1 (850g) after detecting cronobacter sakazakii bacteria in samples.
An Australian researcher has expressed concerns about consumers' tendency to 'stack' nootropics — also known as 'smart drugs' — claiming it has unknown effects on health, and urgently requires more research.
Australian firm Freedom Foods is targeting China and parts of South East Asia with its reformulated and repackaged infant formula range, after first entering the Singapore market last year.
Three China health supplement manufacturers were found to have breached advertising rules and regulations.
Hangzhou Wahaha Group will be launching three new probiotic products that are targeted at women, children, and the elderly.
Japan's consumer genetic testing industry is booming, buoying hopes that personalised nutrition firms can tap into demands for tailored products, especially among the elderly.
Japan's Ministry of Health, Labour and Welfare has revised an ordinance to permit the production and sale of liquid infant formula, leading some of the country's biggest players to express an interest in entering the market.
DSM said it was striving to work with manufacturers to tap into the rising trend of snacking and increasing number of convenience stores, in order to make nutritional products more affordable and accessible.
India regulator FSSAI has published updated rules for food fortification standards, as part of its efforts to make the practice part of the national agenda.
Establishing tolerable upper limits (TUL) and allowing health claims based on regulations from overseas can help India's supplement sector 'self-regulate', and grow the market to US$10bn by 2025.